What is Arbutus Biopharma Corporation's total revenue?

Arbutus Biopharma Corporation (ABUS) reported total revenue of $179.13M in Q1 2026.

How has Arbutus Biopharma Corporation's total revenue changed year-over-year?

Arbutus Biopharma Corporation's total revenue increased by 10054.5% year-over-year, from $1.76M to $179.13M.

What is the long-term trend for Arbutus Biopharma Corporation's total revenue?

Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's total revenue has grown at a 6.4% compound annual growth rate (CAGR), from $10.99M to $14.08M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Arbutus Biopharma Corporation ABUS Total Revenue

Total Revenue at other companies

Arrowhead ResearchARWR

$73.74M-86.4%

Gilead SciencesGILD

$6.96B+4.4%

ALN

Alnylam PharmaceuticalsALNY

$1.17B+96.4%

AnaptysBio, Inc.ANAB

$25.56M-8.0%

Vir Biotechnology, Inc.VIR

-$29K-101%

AbCellera Biologics Inc.ABCL

$8.32M+96.3%

Segments

By product

See full

Revenue from collaborations and licenses$178.74M+21,912%

Collaborations and licenses$1.32M—

Non-cash royalty revenue$181K-59.6%

By segment

See full

Reportable Segment$179.13M+10,055%

Other financials

Income statement

See full

Operating income$168.9M+757%

Net income$169.7M+792%

EPS (diluted)$0.87+769%

Balance sheet

See full

Cash & equivalents$23.7M-36.1%

Total debt$631.0K-46.9%

Total equity$260.2M+229%

Total assets$277.2M+137%

Cash flow

See full

Operating cash flow-$8.1M+39.4%

CapEx--100%

Free cash flow-$4.7M+55.0%

Valuation

See full

Market cap$881.02M+34.1%

Enterprise value$857.94M+38.1%

P/E5.5×—

P/S4.6×-98.0×

Profitability

See full

Operating margin81.7%+42.1pp

Net margin84%+43.4pp

FCF margin-281.5%-119pp

Returns & leverage

See full

Return on equity94.7%+65.1pp

Debt / equity0×0.0×

Current ratio54.3×+48.3×

Where this comes from

Reported directly by Arbutus Biopharma Corporation in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arbutus Biopharma Corporation's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arbutus Biopharma Corporation's total revenue?: Arbutus Biopharma Corporation (ABUS) reported total revenue of $179.13M in Q1 2026.
How has Arbutus Biopharma Corporation's total revenue changed year-over-year?: Arbutus Biopharma Corporation's total revenue increased by 10054.5% year-over-year, from $1.76M to $179.13M.
What is the long-term trend for Arbutus Biopharma Corporation's total revenue?: Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's total revenue has grown at a 6.4% compound annual growth rate (CAGR), from $10.99M to $14.08M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.